Edesa Biotech, Inc.
NASDAQ:EDSA
Overview | Financials
Company Name | Edesa Biotech, Inc. |
Symbol | EDSA |
Currency | USD |
Price | 4.369 |
Market Cap | 14,187,847 |
Dividend Yield | 0% |
52-week-range | 2.46 - 8.33 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Pardeep Nijhawan FRCPC, M.D. |
Website | https://www.edesabiotech.com |
An error occurred while fetching data.
About Edesa Biotech, Inc.
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD